Zensar Technologies to buy US firm BridgeView Life Sciences

Pune-based Zensar Technologies said in a statement, “This strategic move strengthens Zensar's Healthcare and Life Sciences (HLS) vertical and expands its pharma commercial and product launch expertise." The company is part of the $4.8 billion conglomerate RPG Group, has a total services revenue at $591.3 million as on FY24 with the US contributing to 67.2% of the revenue share.